Form 4: Myriad Genetics CFO Scott Leffler Reports Stock Award and Disposal

Chief Financial Officer Scott J. Leffler of Myriad Genetics reported the acquisition of restricted stock units and the disposal of common stock on March 14, 2024.

Summary

• On March 14, 2024, Scott J. Leffler, the Chief Financial Officer of Myriad Genetics, reported a transaction involving the company's stock.
• Leffler acquired 46,095 shares of common stock at $0, likely through a grant of restricted stock units.
• Concurrently, Leffler disposed of 163,865 shares of common stock.
• Following these transactions, Leffler directly owns 163,865 shares of Myriad Genetics.
• The acquired restricted stock units vest in three equal annual installments starting one year from the grant date, according to the company's 2017 equity incentive plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the CFO's stock transactions as an indicator of management's confidence in the company.

Key Dates